Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.55
Delayed Data
As of 3:59pm ET
 +0.15 / +6.25%
Today’s Change
1.81
Today|||52-Week Range
3.35
+23.19%
Year-to-Date

Today’s Trading

Previous close2.40
Today’s open2.42
Day’s range2.40 - 2.55
Volume2,629,532
Average volume (3 months)1,631,497
Market cap$382.0M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book3.12

Competitors

 Today’s
change
Today’s
% change
NSTGNanoString Technolog...+0.45+2.58%
BOLDAudentes Therapeutic...+0.38+2.63%
MCRBSeres Therapeutics I...+0.42+4.30%
CRISCuris Inc+0.06+2.35%
Data as of 4:00pm ET, 04/25/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs